‘Immense progress': Use of restraint and seclusion in mental health centres falls
mental health
centres over the last seven years, a new report has found.
Since January 1st, 2023, the rules around the use of restrictive practices were changed to prioritise 'dignity, autonomy and wellbeing of services users'.
The changes were the latest step by the State to move towards a human rights-based approach to mental health treatment in Ireland.
On Thursday, the
Mental Health Commission
(MHC), which regulates the sector, published a report on the prevalence of restrictive practices.
READ MORE
According to the data, the number of people who were secluded fell from 473 in 2023, to 434 in 2024. This is a significant drop on 2022 – the last year when the old rules were in place – when 620 people were secluded.
This equals a 30 per cent reduction in the number of people secluded between 2022 and 2024, and a 43 per cent reduction from 2018 to last year. Seclusion is defined as a person being unable to leave a room.
The number of people physically restrained also decreased, falling from 1,078 people in 2022 to 879 in 2023 and 844 in 2024. This represents a 22 per cent decrease since 2022 and a 30 per cent decrease since 2018.
Physical restraint is when one or more individual restrains a person, while mechanical restraint is the
use of devices or bodily garments that prevent or limit a patient's movement.
Two approved centres reported use of mechanical restraint in 2023, and only one in 2024. Six residents were restrained over nine episodes in 2023, and five residents over 10 episodes last year.
[
Why is mental health so much worse among Irish youths than adults?
Opens in new window
]
All episodes in 2023 and 2024 were described as being used for 'transfer purposes to and from court/hospital' where there was an immediate threat of serious harm.
The January 2023 regulations from the MHC also banned the use of mechanical restraint on children. The total number of restrictive practice episodes in
Child and Adolescent Mental Health Services
(CAMHS) fell from 2,608 episodes in 2018 to just 238 in 2024.
There was a 57 per cent decrease in physical restraint episodes in Camhs between 2023 and 2024, and an 80 per cent decrease in seclusion episodes.
Prof Jim Lucey, the State's inspector of mental health services, said children are 'specifically protected' from restrictive practices in Irish mental health care.
'Seclusion and physical restraint can have adverse implications for their emotional development. This approach, underpinned by the principles of trauma-informed care, has been further enhanced by the revised regulations.
'Our report documents a profound decline, showcasing the immense progress we have made by working together with staff in services in protecting a particularly vulnerable group.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Daily Mirror
11 hours ago
- Irish Daily Mirror
Chikungunya virus symptoms, spread and what to know as 7,000 infected in China
A mosquito-borne virus that has infected more than 7,000 people across 13 cities in southern China is prompting measures similar to those taken during the Covid pandemic - despite not being contagious between humans. The chikungunya virus, which causes fever, joint pain, headaches and muscle aches, is spreading rapidly across Guangdong province, just north of Hong Kong. Chikungunya is typically uncommon in China, but infections soared after an imported case was detected in Foshan city on July 8, which has since become the worst-affected area, reports New York Times. In Foshan city patients diagnosed with chikungunya are required to remain in hospital under mosquito net protection and can only be discharged after testing negative or completing a mandatory week-long stay, according to a translation of Chinese news outlet NF News. Authorities in Guangdong are doing door-to-door inspections checking for stagnant water - where mosquitos breed - and warning that those who fail to comply can be fined or face criminal charges for "obstructing the prevention of infectious diseases", as outlined in a government flyer translated by the Times. A drone sprays insecticide on August 1, 2025 in Guangzhou, Guangdong Province of China (Image: China News Service via Getty Images) Other measures include releasing mosquito-eating fish into ponds, spraying pesticides, deploying drones to spot breeding sites and even introducing giant "elephant mosquitoes" whose larvae devour the virus-carrying kind. While the current outbreak is centred in Asia, Ireland has recorded a travel-related case of the virus in the past. According to the Health Protection Surveillance Centre (HPSC), the most recent known Irish case was in 2016, involving a person who had recently returned from Kenya. Chikungunya is classed as a notifiable disease in Ireland - meaning health officials must report suspected cases to authorities. While it cannot be transmitted person-to-person, the virus can be passed to humans through the bite of an infected Aedes mosquito, which are usually found in the warmer parts of the world, especially Asia, the US and the Mediterranean Basin. What is Chikungunya? The HPSC said: "Chikungunya is a viral infection caused by the Chikungunya virus, an Alphavirus and member of the Togaviridae family. Chikungunya fever is a notifiable disease in Ireland." What are the symptoms ? The HPSC said: "The time between being bitten by an infected mosquito and developing symptoms ranges from 1 to 12 days, with an average of three to seven days. "The main symptoms are fever, joint pain, muscle pain and headache. Joint pains are a characteristic symptom. Bleeding from the nose or gums may happen, particularly in children. "While most cases recover without complications, some people may develop a more chronic phase with persistent joint pains. Recovery may take several weeks for these patients, coinciding with extreme tiredness. Younger people tend to recover in a matter of a one or two weeks while middle-aged and elderly tend to take one to three months for full recovery." How is it spread? The HPSC said: "Chikungunya fever is transmitted to humans by biting Aedes mosquitoes, such as A. aegypti, A. albopictus and A. polynesiensis. These are tropical and subtropical mosquitoes found in the warmer parts of the world, especially Asia, the United States and the Mediterranean Basin. " Where does it occur? The HPSC said: "Chikungunya is commonly found in East Africa, Southeast Asia and in the Indian sub-continent. In summer 2007, an outbreak was reported in the Emilia-Romagna region of North-East Italy, and this region is now considered an area where Chikungunya virus transmission takes place. The most recent cases of Chikungunya in Italy have occurred between June and October 2017 in Rome, the coastal region of Anzio and Latina. "One case of chikungunya was reported in Ireland during 2016, with a recent travel history to Kenya." What do I need to do if I visit an area with Chikungunya? The HPSC said: "Travellers to affected areas are advised to prevent mosquito bites. Pregnant women, immunosuppressed people and people suffering from a severe chronic illness should consult their physicians prior to the travel in order to assess their risk and get recommendations on personal preventive measures. "All travellers to countries where Chikungunya occurs should take the following steps to prevent mosquito bites: Use of anti-mosquito devices (insecticide-treated bed nets, spray, repellents) Mosquito repellent based on a 30% DEET concentration is recommended. Pregnant women and children under the age of 12 years should consult a physician or pharmacist before use. For newborn children under three months, repellents are not recommended and insecticide-treated bed nets and protective clothing should be used instead. Wear long sleeves and trousers." .Subscribe to our newsletter for the latest news from the Irish Mirror direct to your inbox: Sign up here.
Irish Times
14 hours ago
- Irish Times
Ireland has potential to become global leader in femtech, report says
Ireland could become a global leader in technology, research and innovation focused on women's health, if the right supports are put in the place, a new report has said. The new report, Femtech in Ireland: The Case for Prioritising Women's Health Research and Innovation, is calling on the Government to prioritise the development of femtech in Ireland, by offering greater supports for femtech research and start-ups, and integrate femtech into national health innovation strategies. Ireland has a strong background in medtech, digital health and pharmaceuticals, but femtech is underdeveloped and underfunded, despite women making up half the population. The report is seeking focused funding calls for women's health research and innovation through State agencies, specific funding to commercialise that research, and the establishment of a femtech lab in a healthcare setting with a fast access to clinicliniciansients, data and a test-bed. READ MORE It s also encouraging researchers, clinicians and academics to investigate conditions that affect women only, differently and disproportionately, highlighting the need for the inclusion of sex and gender analysis in research design. The report, which was produced by Health Innovation Hub Ireland (HIHI), and the Department of Obstetrics and Gynaecology at University College Cork (UCC), says improving support for women's health innovation and entrepreneurship could not only address health inequities, but also offer additional economic potential for Ireland, while also strengthening Ireland's life sciences and technology sectors. 'We need to invest in women's health – not just for equality, but because it's smart research, healthcare, and smart economics. There is a real buzz in the femtech innovation sector in Ireland today, with new ideas and start-ups being developed throughout the country,', said Dr Tanya Mulcahy, Director of HIHI and founder of FemTech Ireland. 'We've supported many of them through HIHI, enabling access to clinicians, patients and researchers. It's a sector that is attracting female founders, and provides a new avenue for young researchers, but it's a sector that needs more support- this report is our call to action.' The femtech sector itself is expected to be worth more than $97 billion by 2030, while closing the women's health gap could give the global economy a $1 trillion boost each year by 2040. It could also help unlock new medical treatments and interventions for the wider population. The sector could also encourage more woman founders into the start-up sector, with more than 75 per cent of femtech companies having a woman founder. Minister for Health Jennifer Carroll MacNeill said the report was an important step toward better care for women across Ireland. 'It supports the work we're already doing through the Women's Health Taskforce and highlights how innovation can help us go even further.' The report was also welcomed by Minister for Enterprise, Tourism and Employment Peter Burke. Ireland's first programme to support innovation in women's health, Femtech@HIHI, was launched two years ago. It has now supported more than 30 Irish start-ups that developing everything from wearable tech to track menopause symptoms, to smarter devices for pelvic health and fertility, all aimed at supporting women's health. 'We are witnessing extraordinary advances in healthcare technology and innovation,' said Professor John R Higgins, principal investigator of Health Innovation Hub Ireland and Professor of Obstetrics and Gynaecology, University College Cork and Cork University Maternity Hospital. 'In women's health however, a long-standing gap in research has meant that these innovations have not always translated into meaningful solutions. This gap in evidence directly impacts the development of technologies. Now is the time to bridge that divide – with focused funding, targeted research, and innovation supports.'
The Journal
16 hours ago
- The Journal
Daughter of Waterford woman who died from bowel cancer calls for lower screening age
NOELLE DROHAN WAS never really one to complain, or even draw attention to herself. She was a trained accounts technician, and she worked in the garage across the road from her family home in Dungarvan, Co. Waterford, but her daughters say that her main occupation 'was as a always mam'. 'She put myself and my sister first, always, and I suppose she was like a lot of Irish women in that sense,' Niamh Drohan said. Niamh is 34, and just over a year ago, her mother died with colorectal cancer. Throughout her mum's cancer journey, from the first GP visit over worrying symptoms, to after the diagnosis point, Niamh always had the sense that Noelle was holding information back; that the outlook was much worse than what she was saying. Noelle was 55 when she died on 21 July 2024, she was 53 when she first went to the GP. 'My mam was a really private person, she probably suffered in silence for a really long time before she sought out medical attention. She was incredibly unlucky with her health; I was living in Cork and my sister was living in Dublin for the last few years, and it seemed like every time we were back home, she wasn't well in some way,' Niamh said. Niamh said that when she went home to visit she would notice digestive aids around the house, and that her mother's health seemed to have visibly deteriorated. 'Afterwards, when the reality of the situation was clear, she told me that at that time, it was taking her an hour to get dressed in the mornings. She'd put her leggings on and then have to lie down for half an hour, before she could put her t-shirt on,' Niamh said. In February 2023, after several GP visits, Noelle was sent for a full blood panel test. 'They found that her white blood cell count was on the floor, and she was sent to the hospital immediately,' Niamh said. Noelle underwent chemotherapy treatment and appeared to respond well to it during that year, but when Niamh went home for Christmas, she noticed that her condition had seriously deteriorated. 'At that time, she wasn't fully telling me what was going on, but at that time I was crying on the phone to my friends saying, 'I swear to god I think she's dying,' and they didn't know what to say. Noelle's condition worsened to the point that it was clear to her family that her cancer was terminal. 'She came home for the last time in June, and she had a walker to help her get around. At that stage the cancer had spread extensively, even to her spine,' Niamh said. Advertisement Her mam's passing in July 2024 was devastating to her. 'Of course, she was my mam, so I'd say this, but she really was so maternal with everyone,' Niamh said. Afterwards, Niamh started putting together a picture of their family's health history. Her grandmother had passed away with colorectal cancer at the age of 63, so she realised that there was potentially a genetic factor at play. 'I started looking into the latest reports around colorectal cancer in Ireland and in the world, and I saw that there is an increasing prevalence of colorectal cancer cases in people who are well under the screening age, so it made me start to think that the screening age itself in Ireland should be lowered from 59 to 50, because that is what it is the UK, and in other countries around the world,' Niamh said. Niamh is encouraging people to participate in HIQA's consultation programme for increasing the age range for colorectal screening in Ireland. It's understood that currently, the uptake for the colorectal cancer screening programme is at 46%, which is well below the participation for the other national cancer screening services. Just last week, the Health Information and Quality Authority launched a public consultation assessment as it is in the process of looking into lowering the age of the BowelScreen programme to people aged 50-54 in Ireland. Colorectal cancer, which is also referred to as bowel cancer, refers to cancer that occurs in the colon and rectum. It is the second most common cancer in men and the third most common cancer in women in Ireland It is the third leading cause of cancer-related deaths in Ireland. The screening process is fairly simple, at first it involves an at-home test which is intended to detect hidden blood in a person's stool, and if that is detected, they are sent for a colonoscopy. Similar to the cervical cancer screening programme, it can detect early health indicators and early intervention can prevent a person's cancer from developing to a more serious stage. Dr Máirin Ryan, the deputy CEO of HIQA, said that the HSE already has a commitment in place to expand colorectal cancer screening to people aged 55-74, as currently the service is only totally in place for people aged 59 to 69, although the expansion of the age range is already underway. 'The services required for screening are under pressure to meet existing demands. Significant investment and planning would be required to ensure the necessary resources are in place to support a potential future extension of the BowelScreen programme,' Dr Ryan said. To participate in the public consultation, visit the HIQA site here. *Bowel cancer and colorectal cancer are interchangeable terms. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
